methoxyhydroxyphenylglycol has been researched along with naloxone in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (65.38) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 1 (3.85) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassens, G; Orsulak, P; Reigle, T; Roffman, M; Schildkraut, JJ | 1 |
| Crawley, JN; Laverty, R; Roth, RH | 1 |
| Cowan, A; Dettmar, PW; Walter, DS | 1 |
| Kleber, HD; Kosten, TR; Morgan, C | 1 |
| Ishikawa, K; Kogure, M; Kubo, T; Shibanoki, S | 1 |
| Izumi, H | 1 |
| Mizoguchi, K; Shimizu, T; Tanaka, M; Tsuda, A; Yokoo, H; Yoshida, M | 1 |
| Berridge, CW; Dunn, AJ | 1 |
| Bongianni, F; Carla, V; Moroni, F; Pellegrini-Giampietro, DE | 1 |
| Charney, DS; Heninger, GR | 1 |
| Esposito, E; Kruszewska, A; Ossowska, G; Samanin, R | 1 |
| Elsworth, JD; Garcia, EJ; Grant, SJ; Redmond, DE; Roth, RH; Taylor, JR | 1 |
| Ida, Y; Tanaka, M; Tsuda, A | 1 |
| Moore, MJ; Reigle, TG; Wilhoit, CS | 1 |
| Buchsbaum, MS; Cohen, RM; Davis, GC; Defraites, EG; Elchisak, MA; Jimerson, DC; Kalin, NH; Naber, D; Pickar, D; Risch, SC | 1 |
| Hoaki, Y; Ida, Y; Kohno, Y; Nagasaki, N; Tanaka, M | 1 |
| Charney, DS; Galloway, MP; Heninger, GR; Kleber, HD; Murberg, M; Redmond, DE; Roth, RH | 1 |
| Elsworth, JD; Redmond, DE; Roth, RH | 2 |
| Hoaki, Y; Ida, Y; Iimori, K; Kohno, Y; Nagasaki, N; Nakagawa, R; Tanaka, M; Tsuda, A | 2 |
| Funada, M; Misawa, M; Narita, M; Suzuki, T | 1 |
| Funada, M; Misawa, M; Mizoguchi, H; Narita, M; Suzuki, T; Tsuda, M | 1 |
| Hinton, RK; Kuhn, CM; Little, PJ; Price, RR | 1 |
| Kamei, J; Ohsawa, M | 1 |
| Castells, MT; Laorden, ML; Martínez, MD; Martínez, PJ; Milanés, MV | 1 |
4 trial(s) available for methoxyhydroxyphenylglycol and naloxone
| Article | Year |
|---|---|
Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
Topics: Adult; Blood Pressure; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1992 |
Alpha 2-adrenergic and opiate receptor blockade. Synergistic effects on anxiety in healthy subjects.
Topics: Adult; Anxiety Disorders; Drug Synergism; Erectile Dysfunction; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naloxone; Receptors, Adrenergic, alpha; Receptors, Opioid; Yohimbine | 1986 |
Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers.
Topics: Adult; beta-Endorphin; Catecholamines; Endorphins; Growth Hormone; Homovanillic Acid; Hormones; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naloxone; Placebos; Prolactin | 1981 |
Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
Topics: Adult; Blood Pressure; Brain; Female; Humans; Kinetics; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Narcotics; Norepinephrine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
22 other study(ies) available for methoxyhydroxyphenylglycol and naloxone
| Article | Year |
|---|---|
Further studies of the effects of morphine on the levels of MHPG-SO4 in rat brain.
Topics: Animals; Brain; Desipramine; Glycols; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Norepinephrine; Pargyline; Rats; Time Factors | 1979 |
Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal.
Topics: Animals; Clonidine; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Morphine Dependence; Naloxone; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1979 |
The effect of acute doses of buprenorphine on concentrations of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) in the rat forebrain [proceedings].
Topics: Animals; Brain; Cyclopropanes; Glycols; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Morphinans; Naloxone; Narcotic Antagonists; Phenylacetates; Rats | 1976 |
Naloxone affects both pharmacokinetics and pharmacodynamics of morphine. Application of direct correlation analysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Corpus Striatum; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Protein Binding; Rats; Rats, Inbred Strains; Statistics as Topic; Sulfobromophthalein | 1991 |
Participation of opioid peptide (beta-endorphin) and norepinephrine in the control of compound 48/80-induced hypovolemic thirst in the rats.
Topics: Angiotensin II; Animals; beta-Endorphin; Blood Volume; Catecholamines; Hypothalamus; Injections, Intraventricular; Injections, Subcutaneous; Male; Methoxyhydroxyphenylglycol; Naloxone; Norepinephrine; p-Methoxy-N-methylphenethylamine; Rats; Rats, Inbred Strains; Thirst | 1991 |
Psychological stress-induced increases in noradrenaline release in rat brain regions are attenuated by diazepam, but not by morphine.
Topics: Amygdala; Animals; Brain Chemistry; Corticosterone; Diazepam; Electroshock; Hypothalamus; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Norepinephrine; Rats; Rats, Inbred Strains; Stress, Psychological | 1991 |
Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Biogenic Amines; Brain; Catecholamines; Chromatography, High Pressure Liquid; Corticotropin-Releasing Hormone; Dopamine; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Methoxyhydroxyphenylglycol; Mice; Naloxone; Norepinephrine; Serotonin; Stress, Physiological; Tissue Distribution; Tryptophan | 1987 |
Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.
Topics: Animals; Behavior, Animal; Brain Chemistry; Calcium Channel Blockers; Methoxyhydroxyphenylglycol; Morphine; Morphine Dependence; Naloxone; Nicotinic Acids; Nimodipine; Norepinephrine; Rats; Receptors, Opioid; Substance Withdrawal Syndrome; Verapamil | 1986 |
Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.
Topics: Animals; Behavior, Animal; Clonidine; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Neurons; Norepinephrine; Rats; Substance-Related Disorders | 1987 |
Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
Topics: Animals; Behavior, Animal; Body Weight; Brain Chemistry; Clonidine; Hippocampus; Injections; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1988 |
Naloxone, given before but not after stress exposure, enhances stress-induced increases in regional brain noradrenaline release.
Topics: Animals; Brain; Male; Methoxyhydroxyphenylglycol; Naloxone; Norepinephrine; Rats; Rats, Inbred Strains; Stress, Physiological; Time Factors; Tissue Distribution | 1988 |
Analgesia and increases in limbic and cortical MOPEG-SO4 produced by periaqueductal gray injections of morphine.
Topics: Analgesics; Animals; Behavior, Animal; Cerebral Cortex; Glycols; Injections; Limbic System; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Rats; Rats, Inbred Strains; Reaction Time; Time Factors | 1982 |
Differential modification by opioid agents of acutely enhanced noradrenaline release in discrete brain regions.
Topics: Animals; Brain Chemistry; Glycols; Immobilization; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Opioid; Stress, Physiological | 1983 |
Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
Topics: Animals; Brain; Clonidine; Dose-Response Relationship, Drug; Haplorhini; Humans; Methoxyhydroxyphenylglycol; Morphine Dependence; Naloxone; Neurons; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1982 |
Naloxone enhances stress-induced increases in noradrenaline turnover in specific brain regions in rats.
Topics: Amygdala; Animals; Brain; Cerebral Cortex; Corticosterone; Hippocampus; Hypothalamus; Male; Medulla Oblongata; Methoxyhydroxyphenylglycol; Naloxone; Norepinephrine; Rats; Rats, Inbred Strains; Stress, Physiological; Sulfotransferases; Sulfurtransferases; Thalamus | 1982 |
Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates.
Topics: Animals; Brain; Brain Chemistry; Chlorocebus aethiops; Clonidine; Drug Interactions; Glycols; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Norepinephrine; Piperoxan | 1982 |
Enhancement of stress-induced increase in hypothalamic noradrenaline turnover by pretreatment with naloxone in rats.
Topics: Animals; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Naloxone; Norepinephrine; Rats; Rats, Inbred Strains; Stress, Physiological | 1981 |
Effect of pretreatment with pertussis toxin on the development of physical dependence on morphine.
Topics: Animals; Cerebral Cortex; GTP-Binding Proteins; Male; Methoxyhydroxyphenylglycol; Mice; Morphine Dependence; Naloxone; Norepinephrine; Pertussis Toxin; Virulence Factors, Bordetella | 1993 |
Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Anticonvulsants; Cerebral Cortex; Diazepam; Drug Combinations; gamma-Aminobutyric Acid; Male; Methoxyhydroxyphenylglycol; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Norepinephrine; Receptors, GABA-A; Substance Withdrawal Syndrome | 1996 |
Role of noradrenergic hyperactivity in neonatal opiate abstinence.
Topics: Adrenergic alpha-Agonists; Animals; Animals, Newborn; Brain; Clonidine; Humans; Infant, Newborn; Methoxyhydroxyphenylglycol; Naloxone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Neurologic Examination; Norepinephrine; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley | 1996 |
Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
Topics: Analgesics, Opioid; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Frontal Lobe; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Norepinephrine; Receptors, Adrenergic; Substance Withdrawal Syndrome | 1997 |
Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Norepinephrine; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Suprachiasmatic Nucleus; Supraoptic Nucleus | 2000 |